Roche believes it has exited phase 3 with data to support talks with regulatory agencies, but the mixed results raise ...
Last week, readers were most interested in a story about alternatives to blood as sample types for diagnostic testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback